Tsumura & Co. (4540.T)
Tokyo · JPY · Healthcare · Drug Manufacturers - Specialty & Generic
¥3,733 (-1.24%) as of
Key statistics
- Market cap
- 278.28B
- P/E (TTM)
- 9.26
- Forward P/E
- 8.94
- EPS (TTM)
- 402.92
- Dividend yield
- 4.18%
- 52-week range
- 3,500.00 – 4,403.00
- Revenue (TTM)
- 199.22B
- Profit margin
- 15.16%
- Analyst target
- ¥4,314
- Volume
- 342.50k
About Tsumura & Co.
Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal/throat inflammation symptoms. It is also involved in manufacturing and sales of prescription drugs and over-the-counter Kampo medicines. In addition, it produces and sells alcoholic beverages and food products. Tsumura & Co. was founded in 1893 and is headquartered in Tokyo, Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Tokyo, Japan
- Employees
- 4,923
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.